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1. Introduction 
The vitamin K-dependent coagulation factors are 
known to be synthesized in the liver [ 1,2]. We report 
here that they are also produced by mouse peritoneal 
macrophages in vitro. This finding suggests a role for 
mononuclear phagocytes in extravascular fibrin depo. 
sition, and may also play a role in thrombosis. 
2. Materials and methods 
2 .l . Preparation of macrophage cultures 
Macrophages were obtained from hybrid C3DZF1 
(C3H/Tifo9 X DBA/2 d) mice by peritoneal washing 
with phosphate-buffered saline without anticoagulant. 
Cells were routinely cultured in MEM (minimum 
essential medium with Earle’s salts, Gibco Bio-cult, 
Paisley, Scotland) supplemented with 0.05% (w/v) 
heat inactivated (lOO’C, 10 min) la&albumin hydro- 
lysate (Nutritional Biochemicals Corp., Cleveland, 
OH) and 100 IU/ml of penicillin and streptomycin 
(Gibco Biocult). The cells were either seeded in 
Costar plastic plates (Costar, Broadway, Cambridge, 
MA) in 16 mm circular wells on glass coverslips 
(0.7 X lo6 cells seeded/well) or in 100 mm Falcon 
plastic dishes (20 X lo6 cells seeded/dish). After 2 h 
in culture non-adherent cells were washed away and 
new medium containing lactalbumin hydrolysate was 
added. The incubation took place at 37OC in an 
atmosphere of 5% CO2 in air. The medium collected 
after 24 h in culture was centrifuged at 500 X g and 
the supernatant tested for coagulation factors or sub- 
jected to chromatography on dextran sulphate- 
Sepharose for partial separation of the factors. 
In the experiments with [35S]methionine, cells 
were cultures in medium supplemented with 50 /.&i 
[35S]methionine/ml. After 24 h incubation the 
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medium was collected and subjected to chromato- 
graphy on dextran sulphate-Sepharose column. 
2.2. Dextran sulphate chromatography 
The dextran sulphate column (1.5 X 1 .O cm) was 
equilibrated with 0.025 M Hepes containing 0.05 M 
NaCl and 0.4% sodium citrate. After application of 
the sample, usually 7-l 0 ml macrophage supernatant, 
the column was eluted with a linear gradient of NaCl 
(0.05-0.4 M) in fhe same Hepes-citrate buffer. One 
nil samples were collected and tested for clotting 
activities. 
3. Results and discussion 
Serum-free medium collected after 24 h macro- 
phage culturing ([ 31; see the legend to fig. 1 for details) 
contained significant activities of factors VII, IX, X 
and prothrombin, as determined by one-stage clotting 
assays [4]. Provided that factor X was not activated, 
the concentrations of the various factors remained 
quite constant from one experiment to another; 
compared to a reference standard of normal, pooled 
human plasma the macrophage culture medium con- 
tained 8-12% factor VII, 5-S% factor IX, 7-l 1% 
factor X and 4-7% prothrombin. However, in some 
experiments factor X was partially or fully activated 
to Xa (see below) and in such cultures the level of 
prothrombin was reduced. In addition to the specific 
clotting assays the factors were identified by chro- 
matography on dextran sulphate-Sepharose, which 
yielded the expected elution patterns (fig.1). 
To prove that the coagulation factors were synthe- 
sized in vitro and not carried over from the animal, 
cultures were incubated with [35S]methionine in 
serum free, methionine-free medium. The medium 
was subsequently fractionated on a column of 
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Fig.2. SDS-polyacrylamide gel electrophoresis on factor Xa 
fractions isolated from macrophage supernatants after incu- 
bating the macrophage cultures with (sSS]methionine in 
serum-free, methionine-free medium. Factor Xa was isolated 
from the macrophage supernatant by utilizing the dextran 
sulphate-Sepharose column as in fig.1. Fractions containing 
factor Xa were pooled, concentrated and subjected to SDS- 
polyacrylamide gel eiectrophoresis in the presence of a 
reducing agent, mercaptoethanol, as reported earlier ]S 1. 
The gels, 7 cm long were cut into 40-45 slices, and each &ice 
was tested for YS. 
Fig.1. Chromatography of a macrophage supernatant on a 
dextran sulphate-Sepharose column. Due to varying amounts 
of factor Xa in the culture media, anti~ombin III, 1 mg/ml 
final corm., was added and incubated for 60 min at 4’C 
before assaying for factor IX activity [4]. (0) Factor VII; 
(0) prothrombm; (a) factor IX; (A) factor X. Factor X was 
partially bound to the dextran sulphate-Sepharose as-7O- 
80% of the activity was recovered in the break-through frac- 
tion. All factor Xa together with some native factor X were 
eluted in fractions 18-25. Prothrombin did not bind as the 
whole break-through fraction had the same prothrombin 
activity as the fist 4 fractions eluted after applying the 
NaCl gradient. A normal pooled plasma reference standard 
was prepared. This was arbitrarily said to contain 100% of 
factors VII, IX, X and prothrombin. 
dextran sulphate-Sepharose, and the fractions con- 
taining Xa-activity were analysed further by SDS- 
polyacryiamide gel electrophoresis [S]. As shown in 
fig.2, radioactive peptides were found corresponding 
to Mr 27 000 and 17 000. These two polypeptides, 
obviously synthesized by the macrophages in vitro 
Fig.3. The effect of cycloheximide and warfarin on the 
synthesis of factor X in the macrophages. The cycloheximide 
was added to the cultures at 5 &ml tInal cont. Warfarin was 
added at 12.5 &g/ml &al cone. After culturing the macro- 
phages for 24 h, the medium was collected and tested for 
factor X activity. 
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are identical in size with the heavy and light chains 
of the human factor Xa [9]. 
Coagulation factor activity in macrophage medium 
was also assayed in cultures with added cycloheximide 
and warfarin. Fig.3 demonstrates that both cyclo- 
heximide and warfarin, a vitamin K antagonist, 
prevented the appearance of factor X in the culture 
medium. Similar results were obtained with the other 
vitamin K-dependent coagulation factors (not shown). 
The amounts of activated factor X (Xa) in relation 
to native factor X varied. This variation appeared to 
be correlated to the degree of conta~nation of the 
cultures with lymphocytes. Pure lymphocyte cultures 
did not generate X nor Xa activity. Macrophage cul- 
tures containing 10% non-adherent peritoneal cells 
gave total activation of X to Xa, whereas cultures 
containing -1% non-adherent cells showed only 
-10% conversion of X to Xa. The activation of factor 
X could be reduced to -60% by the use of anti-theta 
antibody and complement [S], control cultures how- 
ing complete activation. It thus appeared that normal 
lymphocytes produced tissue factor or stimulated 
macrophages to produce such factor. The formation 
of Xa is then explained as a result of the action of 
factor VII and tissue factor. 
It seems justified to conclude that mouse perito- 
neal macrophages can produce all the vitamin-K 
dependent coagulation factors. Together with tissue 
factor, these represent all the essential factors 
required to initiate coagulation via the ‘extrinsic sys- 
tem’. 
Our results explain the finding of procoagulant 
activity in mononuclear cell sus~nsions [lo]. Here it 
was demonstrated that stimulated lymphocytes 
caused atremendous increase of procoagulant activity 
when coupling with the macrophages in macrophage 
cultures. 
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